Literature DB >> 22930530

Gene network analysis leads to functional validation of pathways linked to cancer cell growth and survival.

Emmanuelle Berger1, Nathalie Vega, Hubert Vidal, Alain Geloën.   

Abstract

Hepatocellular carcinoma (HCC) represents one of the most frequently diagnosed human cancers; however, there are currently few treatment alternatives to surgical resection. In this study we performed bioinformatic analysis of previously published transcriptomic data in order to characterize liver specific networks, including biological functions, signaling pathways and transcription factors, potentially dysregulated in HCC. By incorporating specific signaling inhibitors into real-time proliferation assays using HepG2 cells, we then validated these in silico results. We found that G protein subunits Gi/G0, protein kinase C, Mek1/2, and Erk1/2 (P42/44), JAK1, PPARA and NFκB p65 subunit were the major signaling molecules required for survival and proliferation of human HCC cell lines. We also found that these pathways regulate the expression of key hepatic transcription factors involved in cell differentiation, such as CEBPA, EGR1, FOXM1 and PPARs. By combining bioinformatic and functional analyses, major signaling pathways related to tumorigenicity in HCC are revealed, thereby elucidating potential targets for drug therapies.
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22930530     DOI: 10.1002/biot.201200188

Source DB:  PubMed          Journal:  Biotechnol J        ISSN: 1860-6768            Impact factor:   4.677


  9 in total

1.  Silencing of FOXM1 transcription factor expression by adenovirus-mediated RNA interference inhibits human hepatocellular carcinoma growth.

Authors:  T Chen; J Xiong; C Yang; L Shan; G Tan; L Yu; Y Tan
Journal:  Cancer Gene Ther       Date:  2014-02-28       Impact factor: 5.987

2.  Pathways commonly dysregulated in mouse and human obese adipose tissue: FAT/CD36 modulates differentiation and lipogenesis.

Authors:  E Berger; S Héraud; A Mojallal; C Lequeux; M Weiss-Gayet; O Damour; A Géloën
Journal:  Adipocyte       Date:  2015-01-26       Impact factor: 4.534

3.  Characterization of pathways involved in colorectal cancer using real-time RT-PCR gene expression data.

Authors:  Samira Shabani; Nasibeh Khayer; Jamshid Motalebzadeh; Tayebeh Majidi Zadeh; Frouzandeh Mahjoubi
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2021

4.  MicroRNA expressions associated with progression of prostate cancer cells to antiandrogen therapy resistance.

Authors:  Richard Ottman; Camha Nguyen; Robert Lorch; Ratna Chakrabarti
Journal:  Mol Cancer       Date:  2014-01-03       Impact factor: 27.401

5.  Aberrantly DNA Methylated-Differentially Expressed Genes and Pathways in Hepatocellular Carcinoma.

Authors:  Changzhou Cai; Weilin Wang; Zhenhua Tu
Journal:  J Cancer       Date:  2019-01-01       Impact factor: 4.207

6.  Identification of genes in hepatocellular carcinoma induced by non-alcoholic fatty liver disease.

Authors:  Changzhou Cai; Xin Song; Chaohui Yu
Journal:  Cancer Biomark       Date:  2020       Impact factor: 4.388

7.  Gene Network Analysis of Glucose Linked Signaling Pathways and Their Role in Human Hepatocellular Carcinoma Cell Growth and Survival in HuH7 and HepG2 Cell Lines.

Authors:  Emmanuelle Berger; Nathalie Vega; Michèle Weiss-Gayet; Alain Géloën
Journal:  Biomed Res Int       Date:  2015-08-24       Impact factor: 3.411

8.  Oleic Acid Uptake Reveals the Rescued Enterocyte Phenotype of Colon Cancer Caco-2 by HT29-MTX Cells in Co-Culture Mode.

Authors:  Emmanuelle Berger; Merian Nassra; Claude Atgié; Pascale Plaisancié; Alain Géloën
Journal:  Int J Mol Sci       Date:  2017-07-20       Impact factor: 5.923

9.  Role of early growth response 1 in liver metabolism and liver cancer.

Authors:  Nancy Magee; Yuxia Zhang
Journal:  Hepatoma Res       Date:  2017-11-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.